Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Daily Stock Opinions and Ratings
Stockchase Opinions

Peter Arender, CFAKing PharmaceuticalsKGTOP PICKSep 03, 2003

Will be volatile. An OK company at a bargain price. Good risk/reward.
Peter Arender, CFAPeter Arender, CFA
Owned
Unlock Rating
$14.20

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

King Pharmaceuticals(KG)

Apr 30, 2004
A potential takeover play. Has been a bit undermanaged and is very cheap.
Photo of David KingDavid KingUnlock Rating
$17.25

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

King Pharmaceuticals(KG)

Dec 19, 2003
Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.
Photo of Ross HealyRoss HealyUnlock Rating
$14.68

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

King Pharmaceuticals(KG)

Sep 25, 2003
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
Photo of Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$15.25

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

King Pharmaceuticals(KG)

Sep 15, 2003
Has great value. US Healthcare looks very inexpensive.
Photo of Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$16.12

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

King Pharmaceuticals(KG)

Aug 22, 2003
Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.
Photo of Matt BaraschMatt BaraschUnlock Rating
$13.97

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

King Pharmaceuticals(KG)

Aug 12, 2003
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
Photo of Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$13.92

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

King Pharmaceuticals(KG)

Jul 14, 2003
Systems indicate a top pick. Cheap and has earnings.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$16.25

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

King Pharmaceuticals(KG)

Nov 07, 2002
Fundamentally should be good, but the stock languishes.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$15.91

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

King Pharmaceuticals(KG)

Aug 16, 2002
Cheap/ Good growth prospects. Only own a small portion in your portfolio.
Photo of Robert FloydRobert FloydUnlock Rating
$19.38

Stock price when the opinion was issued

biotechnologypharmaceutical
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica